IDEXX Laboratories, Inc. (BMV:IDXX)

IDEXX Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	163.97	288.27	453.93	112.55	144.45	383.93
Cash & Short-Term Investments	163.97	288.27	453.93	112.55	144.45	383.93
Cash Growth	-58.74%	-36.50%	303.33%	-22.09%	-62.38%	325.05%
Accounts Receivable	590.4	534.33	512.56	442.47	406.12	355.27
Other Receivables	13.76	26.99	16.97	48.43	19.46	19.48
Receivables	604.15	561.32	529.53	490.9	425.58	374.74
Inventory	395.99	381.88	380.28	367.82	269.03	209.87
Prepaid Expenses	53.34	58.63	48.37	41.74	42	34.56
Other Current Assets	100.16	109.81	83.14	88.46	74.59	59.64
Total Current Assets	1,318	1,400	1,495	1,101	955.66	1,063
Property, Plant & Equipment	833.62	829.25	817.68	768.09	692.77	646.34
Long-Term Investments	31	31	30.25	30.25	5.25	-
Goodwill	407.49	405.1	365.96	361.8	359.35	243.35
Other Intangible Assets	107.41	111.68	84.5	97.67	99.04	52.54
Long-Term Accounts Receivable	189.88	185.51	167.96	148.97	122.16	91.68
Long-Term Deferred Tax Assets	123.08	125.63	107.36	55.22	24.78	31.55
Long-Term Deferred Charges	-	-	-	-	122.41	116.09
Other Long-Term Assets	203.59	205.38	190.96	183.29	55.8	50.28
Total Assets	3,214	3,293	3,260	2,747	2,437	2,295
Accounts Payable	120.1	114.21	110.64	110.22	116.14	74.56
Accrued Expenses	366.63	418.33	372.36	364.69	395.77	342.87
Short-Term Debt	319.5	250	250	579	73.5	-
Current Portion of Long-Term Debt	170.93	167.79	75	74.98	75	49.99
Current Portion of Leases	22.13	21.54	19.8	20.43	19.93	17.73
Current Income Taxes Payable	101.93	62.25	86.55	48.55	42.61	42.68
Current Unearned Revenue	35	33.8	37.2	37.94	40.03	42.57
Other Current Liabilities	-	-	-	-	0.6	12.37
Total Current Liabilities	1,136	1,068	951.55	1,236	763.58	582.76
Long-Term Debt	449.8	449.79	622.88	694.39	775.21	858.49
Long-Term Leases	97	97.84	99.67	101.24	87.38	77.04
Long-Term Unearned Revenue	26.82	26.94	28.53	30.86	41.17	46.16
Long-Term Deferred Tax Liabilities	8.11	11.31	7.24	8.15	8.94	11.71
Other Long-Term Liabilities	47.73	44.34	65.53	67.59	70.94	85.6
Total Liabilities	1,766	1,698	1,775	2,138	1,747	1,662
Common Stock	10.79	10.78	10.75	10.72	10.69	10.65
Additional Paid-In Capital	1,696	1,674	1,570	1,463	1,377	1,295
Retained Earnings	5,575	5,332	4,445	3,600	2,920	2,176
Treasury Stock	-5,749	-5,334	-4,475	-4,392	-3,571	-2,800
Comprehensive Income & Other	-84.24	-87.76	-65.68	-72.61	-47.77	-49.11
Total Common Equity	1,448	1,595	1,485	608.74	689.99	632.09
Minority Interest	-	-	-	-	-	0.71
Shareholders' Equity	1,448	1,595	1,485	608.74	689.99	632.8
Total Liabilities & Equity	3,214	3,293	3,260	2,747	2,437	2,295
Total Debt	1,059	986.95	1,067	1,470	1,031	1,003
Net Cash (Debt)	-895.39	-698.68	-613.42	-1,357	-886.56	-619.32
Net Cash Per Share	-10.82	-8.39	-7.30	-16.05	-10.24	-7.14
Filing Date Shares Outstanding	80.42	81.33	83.09	82.9	84.25	85.43
Total Common Shares Outstanding	80.74	81.6	83.03	82.89	84.56	85.45
Working Capital	181.4	331.98	543.71	-134.33	192.08	479.98
Book Value Per Share	17.93	19.55	17.88	7.34	8.16	7.40
Tangible Book Value	933.12	1,079	1,034	149.27	231.61	336.2
Tangible Book Value Per Share	11.56	13.22	12.45	1.80	2.74	3.93
Land	-	23.99	22.4	22.22	22.64	13.98
Buildings	-	446.16	432.04	356.05	329.09	319.38
Machinery	-	891	837.15	772.56	728.74	686.49
Construction In Progress	-	67.14	79.06	97.31	62.34	39.76
Leasehold Improvements	-	119.84	116.35	107.25	93.25	82.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.